Clinical Trial: SWOG S2013

SWOG S2013

Status: Temporarily Closed

NCT#04871542

Immune Checkpoint Inhibitor Toxicity (I-CHECKIT): A Prospective Observational Study

Eligible for screening study DCP 001

S2013 is temporarily closed to accrual on May 6, 2024 effective 12pm Pacific Time.

The Montana Cancer Consortium (MCC) is an independent nonprofit organization whose mission is to bring state-of-the-art cancer care to Montana, Idaho and Wyoming through National Cancer Institute (NCI) sponsored clinical research.

Navigation

About Us

Contact Us

Copyright © Montana Cancer Consortium | All rights reserved